<DOC>
	<DOCNO>NCT02237989</DOCNO>
	<brief_summary>The aim study evaluate symptomatic efficacy native collagen type 2 joint pain function effect urinary biological marker related cartilage degeneration patient knee osteoarthritis .</brief_summary>
	<brief_title>Effects Of Native Collagen Type 2 Treatment</brief_title>
	<detailed_description>39 patient diagnosed knee osteoarthritis separate two group . The 1st group include 19 patient give 1500mg/day paracetamol , 2nd group consist 20 patient give 1500mg/day paracetamol 10mg/day native collagen type 2 three months.Pretreatment posttreatment Visual Analog Scale , Western Ontario McMaster Universities Osteoarthritis Index ( WOMAC ) , 20-m walking time Short Form-36 ( SF-36 ) , Coll2-1 , Coll2-1NO2 Fibulin-3 level urine compare .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Patients age 4570 year diagnosis primary knee OA accord American College Rheumatology ( ACR ) criterion , Kellgren Lawrence radiological stage II III knee pain Patients intraarticular injection physical therapy within last year , previous low extremity surgery , oral treatment glucosamine chondroitin natural health product within last month , serious concomitant systemic disease , peripheral central neurological disorder , hypersensitivity paracetamol seÂ¬vere cardiac , renal , hepatic , hematologic disease</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>knee osteoarthritis , native collagen type 2 , paracetamol</keyword>
</DOC>